Figure 3.
Determination of EphB4 and ephrin-B2 expression in different EC groups using western blot analysis. (A) Representative immunoblots illustrating changes in EphB4 and ephrin-B2 expression. (B) Densitometric quantification of immunoreactive bands of EphB4 and ephrin-B2immunoblot. *P<0.01 vs. the control group; #P<0.01 vs. double ER/PR-negative EC group. EphB4, erythropoietin-producing hepatocyte receptor B4; ER, estrogen receptor; PR, progesterone receptor; EC, endometrial adenocarcinoma; EH, atypical endometrial hyperplasia; Ctr, control.